--- title: "Electromed, Inc. (ELMD.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/ELMD.US.md" symbol: "ELMD.US" name: "Electromed, Inc." industry: "醫療器械" --- # Electromed, Inc. (ELMD.US) | Item | Detail | |------|--------| | Industry | 醫療器械 | | Location | 美股市場 | | Website | [martvest.com](https://martvest.com) | ## Company Profile Electromed, Inc. 開發、制造、營銷和銷售氣道清理治療及相關產品,這些產品在美國和國際上為患者提供高頻胸壁振盪(HFCWO)治療。該公司為肺功能受損的患者提供 SmartVest 氣道清理系統,包括支氣管擴張症和囊性纖維化患者,以及神經肌肉疾病患者,如腦癱、肌肉萎縮症、肌萎縮側索硬化症和術后並發症;SmartVest SQL 系統;SmartVest Clearway 系統,該系統由一個充氣治療服、一個可編程氣脈衝發生器和一個專利的單管道組成,能夠將氣脈衝從發生器傳遞到治療服上,以在胸壁上產生振盪壓力;以及 SmartVest Connect,這是一種無線技術,允許醫生與患者之間... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:13.000Z **Overall: B (0.20)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 32 / 185 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 15.49% | | | Net Profit YoY | 32.96% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 4.39 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 199.60M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 68.86M | | **Multi Score**: B #### Profit Score: A | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 20.20% | A | | Profit Margin | 13.06% | B | | Gross Margin | 78.42% | A | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 15.49% | B | | Net Profit YoY | 32.96% | B | | Total Assets YoY | 5.04% | C | | Net Assets YoY | 4.21% | C | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 765.80% | B | | OCF YoY | 15.49% | B | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.28 | A | #### Debt Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 17.25% | A | ```chart-data:radar { "title": "Longbridge Financial Score - Electromed, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "A", "indicators": [ { "name": "ROE", "value": "20.20%", "rating": "A" }, { "name": "Profit Margin", "value": "13.06%", "rating": "B" }, { "name": "Gross Margin", "value": "78.42%", "rating": "A" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "15.49%", "rating": "B" }, { "name": "Net Profit YoY", "value": "32.96%", "rating": "B" }, { "name": "Total Assets YoY", "value": "5.04%", "rating": "C" }, { "name": "Net Assets YoY", "value": "4.21%", "rating": "C" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "765.80%", "rating": "B" }, { "name": "OCF YoY", "value": "15.49%", "rating": "B" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.28", "rating": "A" } ] }, { "name": "Security", "grade": "A", "indicators": [ { "name": "Gearing Ratio", "value": "17.25%", "rating": "A" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 啟迪醫療 (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | 直覺外科 (US.ISRG) | A | B | C | A | B | B | | 04 | 史賽克 (US.SYK) | A | B | C | C | B | B | | 05 | 波士頓科學 (US.BSX) | B | B | C | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 22.20 | 10/181 | 29.35 | 27.44 | 23.60 | | PB | 4.39 | 90/181 | 5.15 | 4.68 | 3.90 | | PS (TTM) | 2.90 | 68/181 | 3.55 | 3.23 | 2.78 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-20T05:00:00.000Z Total Analysts: **3** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 3 | 100% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 24.26 | | Highest Target | 38.00 | | Lowest Target | 34.00 | ## References - [Company Overview](https://longbridge.com/en/quote/ELMD.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/ELMD.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/ELMD.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.